Cyclin-dependent kinase 2 (CDK2) is a key mediator for EGF-induced cell transformation mediated through the ELK4/c-Fos signaling pathway

Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17

(2012) Juan Guinea-Viniegra et al.   JOURNAL OF CLINICAL INVESTIGATION

p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells

(2012) L. Cen et al.   NEURO-ONCOLOGY

SLC45A3-ELK4 Chimera in Prostate Cancer: Spotlight on cis -Splicing: Figure 1.

(2012) Chandan Kumar-Sinha et al.   Cancer Discovery

CDK-Mediated Regulation of Cell Functions via c-Jun Phosphorylation and AP-1 Activation

(2011) Tony J. Vanden Bush et al.   PLoS One

SLC45A3-ELK4 Is a Novel and Frequent Erythroblast Transformation-Specific Fusion Transcript in Prostate Cancer

(2009) D. S. Rickman et al.   CANCER RESEARCH

Transcriptome sequencing to detect gene fusions in cancer

(2009) Christopher A. Maher et al.   NATURE

Cyclin-Dependent Kinase 3-Mediated Activating Transcription Factor 1 Phosphorylation Enhances Cell Transformation

(2008) D. Zheng et al.   CANCER RESEARCH

Cyclin-Dependent Kinase-3-Mediated c-Jun Phosphorylation at Ser63 and Ser73 Enhances Cell Transformation

(2008) Y.-Y. Cho et al.   CANCER RESEARCH